Erratum: Evaluation of benzaldehyde derivatives as being bovine kidney aldose reductase inhibitors

dc.contributor.authorŞengül, Bülent
dc.date.accessioned2024-10-04T19:05:19Z
dc.date.available2024-10-04T19:05:19Z
dc.date.issued2023
dc.departmentBayburt Üniversitesien_US
dc.description.abstractAldose reductase (AR) catalyzes the production of sorbitol from glucose in the polyol pathway, and it is a critical enzyme that causes an aberrant aggregation of sorbitol in insulin- independent tissues, create some problems including retinopathy, neuropathy, and nephropathy. AR inhibition has been shown to be a viable approach for reducing these side effects. The current study aimed to introduce new AR inhibitors to the literature. For this purpose, benzaldehydes were examined as being AR inhibitors. Firstly, the homogenate was prepared from the bovine kidney, then inhibition studies were carried out. It was found that all derivatives inhibited AR. The inhibitory potency of 4- Phenyl benzaldehyde (3) and 2- Bromobenzaldehyde (6), having IC50 values as 0.23 and 1.37 ?M, respectively, was determined higher than standard inhibitor sorbinil. After in vitro inhibition studies, estimated binding energies and binding modes of derivatives with enzyme were predicted by molecular docking. Compound 3 exhibited a maximum docking score of -8,61 kcal/mol. In conclusion, these compounds especially compound 3 may be guiding agents that can be used to synthesize new drug candidate molecules to treat or prevent diabetic complications.en_US
dc.identifier.endpage190en_US
dc.identifier.issn2149-6366
dc.identifier.issue4en_US
dc.identifier.startpage184en_US
dc.identifier.trdizinid1220789en_US
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1220789
dc.identifier.urihttp://hdl.handle.net/20.500.12403/4333
dc.identifier.volume12en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTürk Doğa ve Fen Dergisien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectInhibitionen_US
dc.subjectmolecular dockingen_US
dc.subjectpolyol pathwayen_US
dc.subjectbenzaldehydesen_US
dc.titleErratum: Evaluation of benzaldehyde derivatives as being bovine kidney aldose reductase inhibitorsen_US
dc.typeCorrectionen_US

Dosyalar